BUDGET-IMPACT ANALYSIS OF ADDING THE NEW 10-VALENT PNEUMOCOCCAL CONJUGATE VACCINATION (PHID-CV) TO ROUTINE INFANT VACCINATION IN CANADA

被引：0
|
作者：
Ismaila, A. S. [1 ]
Pereira, J. A. [1 ]
Robson, R. C. [1 ]
Talbird, S. E. [2 ]
Standaert, B. A. [3 ]
Rawson, N. S. [1 ]
机构：
[1] GlaxoSmithKline Inc, Mississauga, ON, Canada
[2] RTI Hlth Solut, Res Triangle Pk, NC USA
[3] GlaxoSmithKline Biol, Rixensart, Belgium
来源：
VALUE IN HEALTH | 2009年 / 12卷 / 07期
关键词：
D O I：
10.1016/S1098-3015(10)75067-1
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A418 / A418
页数：1
相关论文
共 50 条
  • [41] COST-EFFECTIVENESS ANALYSIS OF PHID-CV ROUTINE VACCINATION PROGRAMME COMPARED TO PCV-13 IN PORTUGAL
    Correia, V
    Andre, S.
    Van de Velde, N.
    VALUE IN HEALTH, 2015, 18 (07) : A597 - A597
  • [42] Immunogenicity of the 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) When Coadministered With Different Neisseria meningitidis Serogroup C Conjugate Vaccines
    Wysocki, Jacek
    Tejedor, Juan C.
    Grunert, Dutlef
    Konior, Ryszard
    Garcia-Sicilia, Jose
    Knuf, Markus
    Bernard, Laurence
    Dieussaert, Ilse
    Schuerman, Lode
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2009, 28 (04) : S77 - S88
  • [43] Comment on: 'Clinical and Economic Impact of a Potential Switch from 13-Valent to 10-Valent Pneumococcal Conjugate Infant Vaccination in Canada', Wilson et al., 22 June 2018
    McGirr, Ashleigh
    Iqbal, Shehzad M.
    Olbrecht, Jan
    Varghese, Lijoy
    INFECTIOUS DISEASES AND THERAPY, 2018, 7 (04) : 535 - 538
  • [44] Comment on: ‘Clinical and Economic Impact of a Potential Switch from 13-Valent to 10-Valent Pneumococcal Conjugate Infant Vaccination in Canada’, Wilson et al., 22 June 2018
    Ashleigh McGirr
    Shehzad M. Iqbal
    Jan Olbrecht
    Lijoy Varghese
    Infectious Diseases and Therapy, 2018, 7 : 535 - 538
  • [45] ECONOMIC ASSESSMENT OF MASS VACCINATION WITH PNEUMOCOCCAL NON-TYPEABLE HAEMOPHILUS INFLUENZAE PROTEIN D CONJUGATE VACCINE (PHID-CV) IN POLAND
    Kawalec, P.
    Holko, P.
    Dziurda, D.
    Glogowski, C.
    VALUE IN HEALTH, 2009, 12 (07) : A423 - A423
  • [46] The 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Coadministered With DTPw-HBV/Hib and Poliovirus Vaccines: Assessment of Immunogenicity
    Bermal, Nancy
    Szenborn, Leszek
    Chrobot, Andrej
    Alberto, Edison
    Lommel, Patricia
    Gatchalian, Salvacion
    Dieussaert, Ilse
    Schuerman, Lode
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2009, 28 (04) : S89 - S96
  • [47] Otitis media in children vaccinated during consecutive 7-valent or 10-valent pneumococcal conjugate vaccination schedules
    Amanda Jane Leach
    Christine Wigger
    Ross Andrews
    Mark Chatfield
    Heidi Smith-Vaughan
    Peter Stanley Morris
    BMC Pediatrics, 14
  • [48] Otitis media in children vaccinated during consecutive 7-valent or 10-valent pneumococcal conjugate vaccination schedules
    Leach, Amanda Jane
    Wigger, Christine
    Andrews, Ross
    Chatfield, Mark
    Smith-Vaughan, Heidi
    Morris, Peter Stanley
    BMC PEDIATRICS, 2014, 14
  • [49] Cost-effectiveness analysis of routine pneumococcal vaccination in the UK: a comparison of the PHiD-CV vaccine and the PCV-13 vaccine using a Markov model
    Delgleize, Emmanuelle
    Leeuwenkamp, Oscar
    Theodorou, Eleni
    de Velde, Nicolas Van
    BMJ OPEN, 2016, 6 (11):
  • [50] Comparative Cost Benefit Analysis of two new Pneumococcal Conjugate Vaccines (PHiD-CV and PCV-13)
    Knoll, S.
    Jochum, D.
    Talbird, S.
    KLINISCHE PADIATRIE, 2010, 222 : S51 - S52
12345